首页> 外文期刊>Geriatric Care >Short-term efficacy of a fixed association of Palmitoylethanolamide and other phytochemicals as add-on therapy in the management of chronic pain in elderly patients: a real-world retrospective study
【24h】

Short-term efficacy of a fixed association of Palmitoylethanolamide and other phytochemicals as add-on therapy in the management of chronic pain in elderly patients: a real-world retrospective study

机译:固定的棕榈酰乙醇酰胺和其他植物化学物质作为附加疗法治疗老年患者慢性疼痛的短期疗效:一项现实世界的回顾性研究

获取原文
       

摘要

Phytochemicals are promising adjuvant agents for the treatment of pain. This study aimed to explore the short-term efficacy and safety of a fixed-dose combined therapy with Palmitoylethanolamide and other phytochemicals as add-on therapy in elderly patients. Data on 47 elderly patients with non-oncologic chronic pain of mild-moderate degree were analyzed in a retrospective, descriptive, no-profit, double-center realworld study. Patients were administered the combined phytochemical therapy for 6 weeks, in addition to analgesics administered when needed. Patients showed a reduction in pain intensity both in mixed ociceptive and in neuropathic pain and improvements in functional abilities, quality of life, and in the subjective belief about the efficacy of treatment. These results were also observed in the small subgroup of patients in monotherapy with phytochemicals (n=13). No adverse event led to treatment withdrawal. This exploratory study suggests that phytochemicals may represent an effective source of analgesics to be added to chemically synthesized drugs, therefore reducing the need of their up-titration and the risk of toxicity. These data must be considered as preliminary and need to be tested in randomized trials.
机译:植物化学物质是用于治疗疼痛的有希望的佐剂。这项研究的目的是探讨固定剂量联合使用棕榈酰乙醇酰胺和其他植物化学物质作为老年患者附加疗法的短期疗效和安全性。在一项回顾性,描述性,非营利性,双中心现实世界研究中,分析了47位轻度至中度非肿瘤性慢性疼痛老年患者的数据。除了在需要时使用镇痛药外,还对患者进行了为期6周的联合植物化学疗法。患者在混合/伤害性疼痛和神经性疼痛中均表现出疼痛强度的降低,并且功能能力,生活质量以及对治疗功效的主观信念得到改善。在使用植物化学单一疗法的一小部分患者中也观察到了这些结果(n = 13)。没有不良事件导致停药。这项探索性研究表明,植物化学物质可能是要添加到化学合成药物中的有效止痛药来源,因此减少了对其进行滴定和毒性风险的需要。这些数据必须视为初步数据,需要在随机试验中进行测试。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号